Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Convalescent plasma is currently one of the leading treatments for COVID-19, but there is a paucity of data identifying therapeutic efficacy. A comprehensive analysis of the antibody responses in potential plasma donors and an understanding of the clinical and demographic factors that drive variant...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Sabra, Pekosz, Andrew, Park, Han-Sol, Ursin, Rebecca, Shapiro, Janna, Benner, Sarah, Littlefield, Kirsten, Kumar, Swetha, Naik, Harnish Mukesh, Betenbaugh, Michael, Shrestha, Ruchee, Wu, Annie, Hughes, Robert, Burgess, Imani, Caturegli, Patricio, Laeyendecker, Oliver, Quinn, Thomas, Sullivan, David, Shoham, Shmuel, Redd, Andrew, Bloch, Evan, Casadevall, Arturo, Tobian, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325184/
https://www.ncbi.nlm.nih.gov/pubmed/32607519
http://dx.doi.org/10.1101/2020.06.26.20139063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325184/
https://www.ncbi.nlm.nih.gov/pubmed/32607519
http://dx.doi.org/10.1101/2020.06.26.20139063

Ejemplares similares